Form 4 for KYNB KYNTRA BIO, INC.
Accepted 2023-07-13 00:00:00 ET · period of report 2023-07-11 · accession 0001209191-23-042247 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-13 | 2023-07-11 | KYNB | Henderson Jeffrey William | Dir | S - Sale | $2.69 | -2,000 | 32.9K | -6% | -$5,380 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-11 | S | D | 2,000 | $2.69 | 32,866 | D | — | — | (F1) Shares sold by the reporting person pursuant to a 10b5-1 trading plan. (F2) Price reported is a weighted-average sales price. The shares were sold at prices ranging from $2.66 to $2.735. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |